The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • TALi Digital (TD1) receives the Therapeutic Goods Administration’s (TGA) tick of approval for its software product ReadyAttentionGo!
  • ReadAttentionGo! is designed to be a cognitive trainer to develop the attention span of children between three and ten years old through digitised and gamified tasks
  • The tablet software has now received certification and approval as a class one medical device, to be used under the direction of a healthcare professional
  • With the TGA approval under its belt, TALi Digital has the green light to promote ReadyAttentionGo! to the Australian market
  • TD1 shares are up 50 per cent to 0.3 cents at 3:28 pm AEDT

Health tech company TALi Digital (TD1) has received approval from the Therapeutic Goods Administration (TGA) for its software product ReadyAttentionGo!

ReadAttentionGo! has been designed as a cognitive trainer to develop the attention span of children between three and ten years old through digitised and gamified tasks.

The tablet program is to be used under the direction of a healthcare professional, rather than as a stand-alone diagnostic or screener. The program has been created to involve “play-based” interactions, complementary to existing therapy.

The company has now received certification and approval for the tablet product as a class one medical device.

The TALi team completed the design and development of the product in February as a ‘software as a medical device’ product, which has been deemed compliant under the quality management system to ensure a safe and effective product design.  

With the TGA approval under its belt, TALi Digital can promote ReadyAttentionGo! to the Australian market.

TD1 shares were up 50 per cent to 0.3 cents at 3:28 pm AEDT.

TD1 by the numbers
More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next